Subgroup Analyses Results of the Petacc8 Phase Iii Trial Comparing Adjuvant Folfox4 with or Without Cetuximab (Ctx) in Resected Stage Iii Colon Cancer (Cc).

AuthID
P-00P-8PV
19
Author(s)
Taieb, J
·
Tabernero, J
·
Mini, E
·
Subtil, F
·
Van Laethem, JL
·
Thaler, J
·
Petersen, L
·
Collette, L
·
Van Cutsem, E
·
Le Malicot, K
·
Rougier, P
·
Salazar, R
·
Bedenne, L
·
Emile, JF
·
Laurent Puig, P
·
Lepage, C
Document Type
Abstract
Year published
2013
Published
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 31, Issue: 15
Conference
49Th Annual Meeting of the American-Society-Of-Clinical-Oncology (Asco), Date: MAY 31-JUN 04, 2013, Location: Chicago, IL, Sponsors: Amer Soc Clin Oncol
Indexing
Publication Identifiers
Wos: WOS:000335419601261
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.